We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Tufts: Pharma Expected to Spend More on Personalized Medicine
Tufts: Pharma Expected to Spend More on Personalized Medicine
November 24, 2010
Up to half of pharma companies’ pipelines involve personalized medicines, and industry expects to increase investment in this area by more than 50 percent over the next five years, a Tufts survey has found.